Oman

Oman’s life sciences ecosystem is rapidly evolving into a premier regional hub, underpinned by the ambitious Oman Vision 2040 strategic framework.

Oman is increasingly recognized for its robust pharmaceutical manufacturing capabilities, with a growing concentration of facilities in the Salalah Free Zone producing high-quality generics and essential medicines for the global market.

In biotechnology, Oman is pivoting toward precision medicine and genomic research, leveraging its unique genetic diversity to drive breakthroughs in personalized healthcare.

The country’s medical device sector is also expanding, characterized by a shift toward digital health solutions, 3D-printed implants and AI-driven diagnostic tools.

Healthcare innovation is further accelerated by the newly established Research and Innovation Authority, which fosters public-private partnerships and streamlines the commercialization of biomedical discoveries.

Muscat has emerged as a vibrant center for academic research and international life science conferences, facilitating global collaboration among industry pioneers.

The government’s commitment to a decentralized healthcare system ensures that advanced medical services and clinical trial infrastructures are accessible across the governorates.

With significant investments in biopharma M&A and specialized wellness ecosystems, Oman offers a stable and attractive environment for foreign direct investment.

Ultimately, the nation is positioning itself as a leader in health and longevity, integrating cutting-edge technology with world-class medical standards to improve global patient outcomes.